Publications
293
Citations
9,140
Est. group size
—
Recurring co-author estimate
Active years
47
Publishing since 1980
Typically publishes in teams of ~17 · 13% small-team papers (≤3 authors) · across 42 venues
- Nivolumab and Ipilimumab (NIVO IPI) as first-line (1L) treatment for patients with metastatic renal-cell carcinoma (mRCC): A real-world benchmarking analysis from the International mRCC Database Consortium (IMDC).
Journal of Clinical Oncology · 2026
- Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer: 5-year outcomes of the randomized DYNAMIC trial
Nature Medicine · 2025
- Exploring Real-World Outcomes of First Line EGFR Inhibitor Use, Cetuximab Versus Panitumumab, in Patients with Left-Sided, RAS Wild-Type, Metastatic Colorectal Cancer
Clinical Colorectal Cancer · 2025
- Treatment patterns and outcomes for younger patients with metastatic castration-resistant prostate cancer (mCRPC); An Australian prospective registry study
Clinical Genitourinary Cancer · 2025
- The Ave–Rec Trial: Phase II Trial of PDL1/PD1 Blockade with Avelumab after Chemoradiotherapy for Locally Advanced Resectable T3B-4/N1-2 Rectal Cancer
Clinical Cancer Research · 2025
- Real world characteristics and outcomes of patients with BRAFV600E-mutant metastatic colorectal cancer in Australia: The COALA project.
Journal of Clinical Oncology · 2025
- Machine Learning Models of Early Longitudinal Toxicity Trajectories Predict Cetuximab Concentration and Metastatic Colorectal Cancer Survival in the Canadian Cancer Trials Group/AGITG CO.17/20 Trials
JCO Clinical Cancer Informatics · 2025
- Exploring the association between Cultural and Linguistic Diversity (CALD) on treatment and outcomes in pancreatic cancer: an analysis of PURPLE real-world registry data from an Australian population
BMC Public Health · 2025
- The association of health-care contact days with physical function and survival in CCTG/AGITG CO.17
JNCI Journal of the National Cancer Institute · 2024
- Transverse Colon Primary Tumor Location as a Biomarker in Metastatic Colorectal Cancer: A Pooled Analysis of CCTG/AGITG CO.17 and CO.20 Randomized Clinical Trials
Clinical Cancer Research · 2024
- A practical guide for the use of apalutamide for non‐metastatic castration‐resistant prostate cancer in Australia
Asia-Pacific Journal of Clinical Oncology · 2024
- Initial Assessment of Resectability of Colorectal Cancer Liver Metastases Versus Clinical Outcome
Clinical Colorectal Cancer · 2024
- Holistic Review of Applicants by the United States Postgraduate Training Programs Is Not Associated With the Percentage of Female Residents
Cureus · 2024
- Evolving patterns of metastatic spread, treatment, and outcome for patients with oligometastatic colorectal cancer
Surgical Oncology Insight · 2024
- Real‐world impact of pembrolizumab availability for deficient mismatch repair metastatic colorectal cancer
Internal Medicine Journal · 2024
- Journal of Clinical Oncology×44
- AEA Randomized Controlled Trials×19
- Annals of Oncology×15
- Asia-Pacific Journal of Clinical Oncology×12
- Clinical Colorectal Cancer×9
- Wei Chen
Medicine · The Ohio State University
- J. Kevin Hicks
Medicine · University of Michigan
- Mingjia Li
Medicine · The Ohio State University
- Yusuf Açıkgöz
Medicine · The Ohio State University
- Eric D. Miller
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile